UBS Group’s MetLife MET Stock Holding History

UBS Group’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.4M	Sell	147,000 -199,900	-58%	-$15M	﹤0.01%	3297
2025 Q4	$27.4M	Buy	346,900 +100,900	+41%	+$7.99M	﹤0.01%	2277
2025 Q3	$20.3M	Sell	246,000 -30,000	-11%	-$2.36M	﹤0.01%	2544
2025 Q2	$22.2M	Sell	276,000 -678,100	-71%	-$52.3M	﹤0.01%	2259
2025 Q1	$76.6M	Sell	954,100 -250,000	-21%	-$20.8M	0.01%	1108
2024 Q4	$98.6M	Buy	1,204,100 +18,500	+2%	+$1.54M	0.02%	942
2024 Q3	$97.8M	Buy	1,185,600 +565,000	+91%	+$42.2M	0.02%	732
2024 Q2	$43.6M	Buy	620,600 +170,600	+38%	+$12.2M	0.01%	1127
2024 Q1	$33.3M	Sell	450,000 -915,700	-67%	-$63.8M	0.01%	1318
2023 Q4	$90.3M	Buy	1,365,700 +9,400	+0.7%	+$588K	0.03%	625
2023 Q3	$85.3M	Buy	1,356,300 +145,700	+12%	+$9.07M	0.03%	567
2023 Q2	$68.4M	Sell	1,210,600 -444,400	-27%	-$24.7M	0.02%	660
2023 Q1	$95.9M	Sell	1,655,000 -891,200	-35%	-$60.1M	0.04%	472
2022 Q4	$184M	Buy	2,546,200 +354,100	+16%	+$25.4M	0.07%	298
2022 Q3	$133M	Buy	2,192,100 +315,000	+17%	+$20.1M	0.06%	326
2022 Q2	$118M	Sell	1,877,100 -44,600	-2%	-$2.95M	0.05%	398
2022 Q1	$135M	Sell	1,921,700 -827,700	-30%	-$56M	0.05%	413
2021 Q4	$172M	Buy	2,749,400 +881,490	+47%	+$55.3M	0.05%	388
2021 Q3	$115M	Buy	1,867,910 +225,000	+14%	+$13.5M	0.04%	491
2021 Q2	$98.3M	Sell	1,642,910 -14,174	-0.9%	-$898K	0.03%	527
2021 Q1	$101M	Buy	1,657,084 +367,384	+28%	+$20.3M	0.03%	512
2020 Q4	$60.6M	Buy	1,289,700 +323,300	+33%	+$14M	0.02%	696
2020 Q3	$35.9M	Buy	966,400 +63,400	+7%	+$2.41M	0.01%	828
2020 Q2	$33M	Buy	903,000 +151,800	+20%	+$5.28M	0.01%	800
2020 Q1	$23M	Sell	751,200 -164,200	-18%	-$7.28M	0.01%	914
2019 Q4	$46.7M	Sell	915,400 -74,500	-8%	-$3.6M	0.02%	819
2019 Q3	$46.7M	Buy	989,900 +426,400	+76%	+$20.3M	0.02%	731
2019 Q2	$28M	Buy	563,500 +157,600	+39%	+$7.41M	0.01%	994
2019 Q1	$17.3M	Buy	405,900 +221,700	+120%	+$9.8M	0.01%	1238
2018 Q4	$7.56M	Buy	184,200 +110,700	+151%	+$4.75M	﹤0.01%	1809
2018 Q3	$3.43M	Sell	73,500 -171,300	-70%	-$7.83M	﹤0.01%	2702
2018 Q2	$10.7M	Buy	244,800 +37,300	+18%	+$1.74M	﹤0.01%	1688
2018 Q1	$9.52M	Buy	207,500 +57,500	+38%	+$2.79M	﹤0.01%	1728
2017 Q4	$7.58M	Sell	150,000 -50,000	-25%	-$2.63M	﹤0.01%	1960
2017 Q3	$10.4M	Sell	200,000 -1,018,492	-84%	-$49.6M	﹤0.01%	1595
2017 Q2	$59.7M	Sell	1,218,492 -720,212	-37%	-$33.4M	0.03%	513
2017 Q1	$91.3M	Buy	1,938,704 +214,414	+12%	+$10.2M	0.05%	360
2016 Q4	$82.8M	Sell	1,724,290 -1,428,530	-45%	-$65.5M	0.05%	380
2016 Q3	$125M	Buy	3,152,820 +1,189,320	+61%	+$44.7M	0.07%	270
2016 Q2	$69.7M	Sell	1,963,500 -558,868	-22%	-$21.8M	0.04%	394
2016 Q1	$98.8M	Buy	2,522,368 +277,695	+12%	+$10.4M	0.07%	280
2015 Q4	$96.4M	Buy	2,244,673 +1,850,066	+469%	+$81.4M	0.06%	318
2015 Q3	$16.6M	Sell	394,607 -125,889	-24%	-$5.88M	0.01%	1020
2015 Q2	$26M	Sell	520,496 -19,916	-4%	-$943K	0.02%	819
2015 Q1	$24.3M	Buy	540,412 +19,604	+4%	+$881K	0.02%	849
2014 Q4	$25.1M	Buy	+520,808	New	+$24.7M	0.02%	866

Other funds holding MET

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

UBS Group's MET Position: Q1 2026 in Review

UBS Group increased its MetLife (MET) stake by 46% in Q1 2026, buying an estimated $85.4M and bringing the position to 3,605,168 shares worth $255M. The position accounts for 0.04% of the portfolio, ranked #500.

UBS Group first reported a position in MET in Q4 2014 and has held it in 46 quarters since. The position peaked at $293M in Q4 2014. 1,372 funds tracked by Wall St. Rank hold MET as of Q1 2026.

UBS Group held 3,605,168 shares of MetLife worth $255M as of Q1 2026.
UBS Group bought 1,140,426 MetLife shares in Q1 2026, an estimated $85.4M.
MetLife made up 0.04% of UBS Group's portfolio in Q1 2026, its #500 holding.
UBS Group first reported a position in MetLife in Q4 2014 and has held it in 46 quarters since.
UBS Group's MetLife position peaked at $293M in Q4 2014.
1,372 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.